ARTICLE | Company News
Cardax, BASF deal
December 11, 2006 8:00 AM UTC
BF will exclusively manufacture a derivative of astaxanthin, an intermediate used to make Cardax's Xancor, which is in preclinical testing to treat cardiovascular inflammatory disease. BF also receive...